[{"data":1,"prerenderedAt":173},["ShallowReactive",2],{"article-\u002Fai":3},{"_path":4,"_dir":5,"_draft":6,"_partial":6,"_locale":5,"title":7,"description":8,"date":9,"tags":10,"listed":13,"body":14,"_type":167,"_id":168,"_source":169,"_file":170,"_stem":171,"_extension":172},"\u002Farticles\u002F\u002Fai","",false,"AI 在生物制药中的作用","从疾病研究、靶点发现、分子设计到临床和上市后监测，梳理 AI 在生物制药流程中的主要位置。","2026-06-05",[11,12],"AI制药","随笔",true,{"type":15,"children":16,"toc":159},"root",[17,26,36,42,48,53,66,72,84,92,97,102,108,113,119,124,132,149,154],{"type":18,"tag":19,"props":20,"children":22},"element","h2",{"id":21},"ai制药过程",[23],{"type":24,"value":25},"text","AI制药过程",{"type":18,"tag":27,"props":28,"children":30},"pre",{"code":29},"疾病研究\n-> 靶点发现\n-> 靶点验证\n-> 先导化合物发现\n-> 分子设计 \u002F 优化\n-> ADMET 预测\n-> 临床前试验\n-> 临床试验\n-> 上市\n-> 上市后监测\n",[31],{"type":18,"tag":32,"props":33,"children":34},"code",{"__ignoreMap":5},[35],{"type":24,"value":29},{"type":18,"tag":19,"props":37,"children":39},{"id":38},"第一阶段",[40],{"type":24,"value":41},"第一阶段：",{"type":18,"tag":43,"props":44,"children":45},"p",{},[46],{"type":24,"value":47},"现在要研发一种病的药，我们要先研究这个病，",{"type":18,"tag":43,"props":49,"children":50},{},[51],{"type":24,"value":52},"通常通过多组学数据(Multi-omics)、临床医学数据和文献挖掘来研究疾病【如测序患者和健康人群的DNA\u002FRNA，寻找突变和异常表达，或者通过蛋白质组学与代谢组学：观察疾病状态下人体内蛋白质和代谢产物的变化】。最终得到致病机理，直接成果通常是异常蛋白。",{"type":18,"tag":43,"props":54,"children":55},{},[56,58,64],{"type":24,"value":57},"注：基因通过指导蛋白质的合成来发挥生物学的功能。我们要找的在疾病发生的过程中起到关键破坏作用的异常蛋白质(也就是我们常称",{"type":18,"tag":59,"props":60,"children":61},"strong",{},[62],{"type":24,"value":63},"靶点",{"type":24,"value":65},")",{"type":18,"tag":19,"props":67,"children":69},{"id":68},"第二阶段",[70],{"type":24,"value":71},"第二阶段：",{"type":18,"tag":43,"props":73,"children":74},{},[75,77,82],{"type":24,"value":76},"然后我们根据致病基因，去找到关键通路(一个基因可以生成很多种蛋白)，",{"type":18,"tag":59,"props":78,"children":79},{},[80],{"type":24,"value":81},"问题三：关键通路怎么找",{"type":24,"value":83},"。找到异常蛋白，分析异常蛋白是否适合当靶点(表面是否太光滑分子不容易抓住)",{"type":18,"tag":43,"props":85,"children":86},{},[87],{"type":18,"tag":59,"props":88,"children":89},{},[90],{"type":24,"value":91},"问题三(关键通路怎么找)：",{"type":18,"tag":43,"props":93,"children":94},{},[95],{"type":24,"value":96},"人体内的蛋白质不是孤立工作的，他们会相互传递信号，形成生物学通路。",{"type":18,"tag":43,"props":98,"children":99},{},[100],{"type":24,"value":101},"AI的角色：AI(特别是图神经网络)，能够完美匹配生物学通路的结构，边=化学键，节点=原子。通过分析，AI能预测哪个\"节点(蛋白质)\"是流量的核心枢纽，断开这个枢纽就能阻止疾病蔓延。",{"type":18,"tag":19,"props":103,"children":105},{"id":104},"第三阶段",[106],{"type":24,"value":107},"第三阶段：",{"type":18,"tag":43,"props":109,"children":110},{},[111],{"type":24,"value":112},"确认靶点后，要找到能够和靶点结合的分子，可以在已有的分子找然后进行优化(虚拟筛选)，也可以设计新的分子(利用生成式AI)",{"type":18,"tag":19,"props":114,"children":116},{"id":115},"第四阶段",[117],{"type":24,"value":118},"第四阶段：",{"type":18,"tag":43,"props":120,"children":121},{},[122],{"type":24,"value":123},"设计出分子后，制成药，**问题四：分子和药的区别是什么。**要对药进行ADMET分析",{"type":18,"tag":43,"props":125,"children":126},{},[127],{"type":18,"tag":59,"props":128,"children":129},{},[130],{"type":24,"value":131},"问题四(分子和药的区别是什么)：",{"type":18,"tag":43,"props":133,"children":134},{},[135,140,142,147],{"type":18,"tag":59,"props":136,"children":137},{},[138],{"type":24,"value":139},"注：",{"type":24,"value":141}," ADMET分析不是“制成药之后”才做的，而是在",{"type":18,"tag":59,"props":143,"children":144},{},[145],{"type":24,"value":146},"第三阶段（分子设计与优化）就已经开始了",{"type":24,"value":148},"，甚至贯穿始终。",{"type":18,"tag":43,"props":150,"children":151},{},[152],{"type":24,"value":153},"后面的事，什么临床一期二期先不谈。",{"type":18,"tag":43,"props":155,"children":156},{},[157],{"type":24,"value":158},"计算机辅助药物设计CADD；AI制药AIDD",{"title":5,"searchDepth":160,"depth":160,"links":161},2,[162,163,164,165,166],{"id":21,"depth":160,"text":25},{"id":38,"depth":160,"text":41},{"id":68,"depth":160,"text":71},{"id":104,"depth":160,"text":107},{"id":115,"depth":160,"text":118},"markdown","content:articles:生信基础:AI制药流程.md","content","articles\u002F生信基础\u002FAI制药流程.md","articles\u002F生信基础\u002FAI制药流程","md",1780895156524]